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Expired or unused medication at people’s homes is normally disposed of in normal garbage, sewage 
system or, in certain cases, returned to the public health system. There is still no specific legislation 
regarding this leftover medication to regulate and orient the handling and correct disposal of medication 
waste. However, there is defined regulation regarding health services’ solid waste. This article has the 
objective of discussing management models for the disposal of medication waste and the recommendations 
made by pertinent national and international legislation. By means of literature reviews, the management 
structure for medication waste of international legislation and the regulations regarding the environment, 
as well as the national legislation for the solid waste from health services was analyzed. Through the 
analysis it was possible to present better clarifications as to the possible impacts to the environment, to 
the public’s health and alternatives in order to obtain the efficient disposal of medication, reducing and/
or avoiding sanitary risk, guaranteeing the quality and safety of public health.
Uniterms: Medications/disposal. Medications/solid waste/disposal. Sanitary risk. Environmental 
contamination. National Solid Waste Policy.
As sobras de medicamentos oriundas do desuso ou da expiração do prazo de validade que constam 
nos domicílios da população, normalmente, são destinadas diretamente para o lixo comum, rede de 
esgoto ou, em alguns casos, devolvidas para a rede pública. Sobre essas sobras, ainda não há legislação 
específica que regulamenta e orienta sobre a manipulação e destinação correta do descarte dos resíduos 
de medicamentos. Entretanto, sobre os resíduos sólidos de serviços de saúde já se possui regulamentações 
definidas. O presente artigo tem como objetivo discutir modelos de gestão de descarte de resíduos de 
medicamentos e as recomendações de legislações internacionais e nacionais pertinentes. Por meio de 
revisão de literatura, analisou-se a estrutura do gerenciamento de resíduos para medicamentos de legislação 
internacional e as regulamentações relacionadas ao meio ambiente, assim como a legislação nacional de 
resíduos sólidos de serviços de saúde. Com a análise foi possível apresentar melhores esclarecimentos 
quanto aos possíveis impactos ao meio ambiente, à saúde da população e alternativas para se obter gestão 
eficaz de descarte de medicamentos, reduzindo e/ou evitando o risco sanitário, garantindo qualidade e 
segurança da saúde pública.
Unitermos: Medicamentos/descarte. Medicamentos/resíduos sólidos/descarte. Risco sanitário. 
Contaminação ambiental. Política Nacional de Resíduos Sólidos.
INTRODUCTION
Towards the end of the 20th century, a growing con-
cern of society with environmental issues was observed, 
engaging in the reformulation of alternatives aiming at 
a balance between economic development and environ-
mental conservation. This objective was especially dealt 
with by the so-called sustainable development or eco-
development (Milaré, 2005).
Concerns with sustainable production have not 
merely been emotional or sterile. Among the many initia-
tives made in reference to the issue, we must mention the 
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international regulation drafted and proposed by ISO – In-
ternational Organization for Standardization, summarized 
in the ISO 14.000 series. This international organization, 
with headquarters in Geneva, has been acting within its 
specific corporate purposes since 1947. Over the last few 
years, it has drafted norms to ensure the quality of in-
dustrial products, the ISO 9.000 series. The norms in the 
ISO 14.000 series aim at protecting, in an environmental 
quality aspect, not only the products, but the productive 
processes as well (Milaré, 2005).
In Brazil, the first indications of concerns with the 
environment are found in the Portuguese legislation, which 
was in effect until the Civil Code was created in 1916 
(Junior et al., 2005).
The greatest movements regarding the subject were 
due to the international conference on the main environ-
mental problems, proposed by Sweden to the UN (Junior 
et al., 2005).
In 1972, in the city of Stockholm, the UN held the 
United Nations Conference on the Human Environment, 
with the participation of 113 countries. From this confer-
ence, the creation of the United Nations Environmental 
Program – UNEP and the inquiries made by third world 
countries, led by Brazil, regarding the attitude of rich 
countries are noteworthy (Junior et al., 2005).
It is also necessary to mention the importance of 
the approval of Law 6.151, of 1974, which deals with 
the National Development Plan - NDP to be executed 
from 1975 to 1979, which incorporates an environmental 
policy concern. Since the country’s first environmental 
regulatory milestone was Law 6.938, of 1981, which deals 
with the National Environmental Policy, its purposes and 
formulation and application mechanisms, and other provi-
sions, and institutes the National Environmental System 
(SISNAMA) (Junior et al., 2005).
The second milestone coincides with the publication 
of Law 7.347, of 1985, which deals with matters such as 
public civil lawsuits as a specific procedural instrument to 
defend the environment, transforming it into a legal matter.
The third milestone came with the Federal Constitu-
tion of 1988, incorporating the environmental issue.
The fourth milestone is represented by Law 9.605, 
of 1998, which deals with legal and administrative sanc-
tions deriving from conduct and activities that harm the 
environment, and includes other provisions; known as the 
“Environmental Crimes Law”
After World War II, precisely in the 60’s, a practical 
awareness begins to take form in the use of natural re-
sources in an adequate manner; raw materials, energy and 
water, among other resources provided by nature, which 
become rarer and more expensive. The environmental 
degradation processes, in various forms, begin to spread. 
New crises, which are more serious and global, take shape 
on the horizon for a society that, without embargo, insists 
on closing its eyes and ears to reality. Heavy clouds pile 
up over the fate of the planet. There is a limit for growth 
as well as a limit for inconsistency. It was then the cry and 
the light from Stockholm that became present, for good. 
From then on, environmental awareness has been extend-
ing itself and becoming more robust (Milaré, 2005).
Thus, Environmental Law is born, which can be 
interpreted as a set of concepts and regulation norms that 
aim at human direct or indirect action to the environment, 
which may damage the environment’s health globally, with 
the objective of maintaining sustainability for the genera-
tions of today and tomorrow (Milaré, 2005).
There is currently a discussion regarding the prob-
lem of solid waste generation, which involves all areas 
of society’s activities, such as techno-scientific, public 
administration, public health, due to the interrelationship 
between the environment and quality of life.
The monitoring of residual pharmaceuticals in the 
environment has gained a lot of interest from society, 
which also has its share of responsibility as to environmen-
tal conservation. This concern is justified because if the 
medications are used and/or improperly discarded into the 
environment through the water, soil and air, may become 
a polluting agent for nature and public health.
The main contributor for this type of contaminant 
in superficial water is the release of untreated sewage, 
considering that there is a huge sanitation infrastructure 
deficit in many locations. Only 20.2% of Brazilian munici-
palities collect and treat domestic sewage, 32% only have 
the collection service and in 47.8% of the municipalities, 
the sewage isn’t collected and is released directly into the 
water. The situation is a little better in the Southeastern 
region, but still, only 33.1% of the municipalities have 
a collection and sewage treatment services, 59.8% only 
collect and 7.1% of the municipalities don’t even have a 
collection service (Melo et al., 2005).
The main point of entry of pharmaceutical waste is 
the release of domestic sewage, treated or not, into water 
systems. However, the pharmaceutical industry effluents, 
rural effluents, the presence of pharmaceuticals in animal 
manure used for the fertilizing of soil and the improper 
disposal of pharmaceuticals after they expire must also 
be taken into consideration (Melo et al., 2005; Eickhoff 
et al., 2009).
Another relevant aspect are the leftover medications 
that originate from the dispensing of excessive medication 
for the treatment, the free samples distributed by the phar-
maceutical laboratories as publicity and the inadequate 
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management of medication inventory by the pharmacies 
and other private or public health establishments. The two 
possibilities for the destination of unused medication are 
to be reused or disposed of. 
Within this context, the objective of the study aims 
at discussing the management models of disposing medi-
cation waste and the recommendations made by pertinent 
national and international legislation.
METHODOLOGY
The study used a descriptive approach of the kind of 
documental qualitative conducted from June to October 
2011. In order to collect data on the structure operates solid 
waste management of drugs and environmental regula-
tions and major waste medicines adopted the technique 
of indirect documentation and literature. Technique was 
used to analyze qualitative data.
The main keywords used were: Dispose of medi-
cines, health risks, environmental contamination and solid 
waste products, national policy on solid waste, chemical 
waste.
The main sources were the databases of scientific re-
search, books on the subject, official websites governmen-
tal organizations (Nacional Sanitary Surveillance Agency, 
European Medicines Agency, World Health Organization).
RESULTS AND DISCUSSION
The international experience with the disposal of 
medication waste
Many pharmacies in the US receive expired or un-
used medication. The cost is estimated at US$ 2 billion per 
year, exceeding the current market value of the products. 
Part of this cost is attributed to the exaggerated consump-
tion of medications (Eickhoff et al., 2009; Daughton, 
2003).
The North American regulation agency does not 
prohibit the reuse of medication and permits each state 
to have its own regulation. 36 states permit some form of 
reuse or resale, 17 permit both practices and 12 prohibit 
both forms (Eickhoff et al., 2009; Daughton, 2003).
There are differences in opinion as to the reuse of 
medication, because in certain cases, there is no way of 
knowing the previous storage conditions, such as the tem-
perature and humidity to which they were exposed. As to 
disposal, in North Carolina the regulations preconize that 
controlled substances must be discarded by incineration, 
through the sewage system or taken to a pharmacy to be 
destroyed (Eickhoff et al., 2009; Daughton, 2003).
There is controversy as to the orientation to dispose 
of medications by flushing them down the toilet, because 
it has been verified that the water is contaminated through 
the sewage system (Eickhoff, et al., 2009; World Helath 
Organization, 1999b).
Canada is one of the countries that have dem-
onstrated great concern regarding the management of 
waste. In 1996, the pharmaceutical industries in British 
Columbia voluntarily established the EnviRX Program 
with the objective of orienting the consumer. In 1997, 
the province’s government expanded the Post-consumer 
Residual Stewardship Program Regulation, which had 
the purpose of accepting all expired over-the-counter and 
certain prescription medications, and not accepting free 
samples (Eickhoff et al., 2009)
The British Columbia pharmacies have been part of 
the Medications Return Program-MRP since 2001. Among 
the justifications to participate in the program, they men-
tion the reduction of accidental poisoning of children by 
expired medications, the reduction of costs, improper self-
medication and the potential damage to the environment 
(Eickhoff et al., 2009; Daughton, 2003).
The Pharmaceutical Association, in the province 
of Alberta, Canada, has been conducting a survey with 
consumers about the discarding of pharmaceutical prod-
ucts, personal care and why they are not completely used 
(Daughton, 2003). Another experiment is a project that 
involves the triage of prescriptions at public and private 
pharmacies, where the pharmacist dispenses an initial 
quantity, and if the medication is tolerated, they dispense 
the rest of the prescribed medication. This alternative has 
the objective of avoiding the waste of medications caused 
by the interruption or change in treatment (Eickhoff et al., 
2009).
Europe has a few programs for reverse medication 
logistics. Italy, France and Spain have presented the larg-
est programs. For certain medical products, the European 
agency recommends that unused or expired preparations 
be returned to the pharmacies (Eickhoff et al., 2009; 
Daughton, 2003).
In Australia, in 1998, a collection program was 
launched in a partnership between the Government of 
New South Wales and several pharmaceutical industries 
(Eickhoff et al., 2009; Daughton, 2003).
International organizations’ recommendations
In 1999, the World Health Organization (WHO) 
published a recommendation guide on the management of 
waste generated by health services, which was called the 
Safe Management of Wastes from Health-care Activities 
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TABLE I - Main national and international laws for solid waste of medicinal products
COUNTRY / AGENCY REGULATORY LAW REGULATORY IMPACT
BRAZIL/SNVS1 Law No. 6360 of 1976 Restructured the norms for the registration and inspection of 
medications that required the prescription to be presented for 
the sale of medications, with the objective of controlling the 
consumption of pharmaceuticals.
BRAZIL/SNVS1 Decree No. 79.094 of 1977 Regulates Law No. 6.360 of September 23, 1976, to submit 
health monitoring system medicines, pharmaceutical 
ingredients, drug related, cosmetics, hygiene products, 
disinfectants and other.
BRAZIL/Presidency of the republic Federal Constitution of 1988 Creation of the Integrated Health System (SUS) and defined 
through Law No. 8.080/90.
BRAZIL/CONAMA2 Resolution No. 006 of 1988 There is the inclusion of chemical industries with more than 
fifty employees in the “industrial waste control”.
BRAZIL/SNVS1 Law No. 9.78 of 1999 Approved, which created the National Sanitary Surveillance 
Agency (ANVISA), a regulatory milestone of the sector.
BRAZIL/ANVISA3 RDC Resolution No. 306 of 2004 Normative instructions for the current waste has adopted its 
classification criterion based on environmental legislation.
BRAZIL/CONAMA2 Resolution No. 358 of 2005 Normative instructions for the current waste has adopted its 
classification criterion based on environmental legislation.
BRAZIL/ABNT4 NBR 10.004 Norm Normative instructions for the current waste has adopted its 
classification criterion.
BRAZIL/ANVISA3 Law No. 12.305 of 2010 Institutes the National Policy on Solid Waste; change the Law 
9605 of February 12, 1998, and other measures.
BRAZIL/ANVISA3 Decree No. 7.404 of 2010 Creates the National Solid Waste Policy’s Inter-ministerial 
Committee, for the implementation of the Reverse Logistics 
Systems.
BRAZIL/MMA5 Ordinance No. 112 of 2011 Establishes Working Group for the purpose of articulating, 
under federal, the implementation of the National Solid 
Waste.
BRAZIL/MMA5 Ordinance No. 113 of 2011 Approves the Internal Rules of the Steering Committee for 
Implementation of Reverse Logistics Systems.
Geneva/WHO6 Guidelines 1999 a Safe disposal of unwanted pharmaceutical in and after 
emergencies.
Geneva/WHO6 Guidelines 1999 b Safe management of wastes from health-care activities.
United States Federal solid waste disposal act of 
1965.
Established Federal standards and requirements for state and 
regional authorities respecting solid waste disposal.
Spain Law Nº 10 of 1998 Preparation of national plans for waste and admits the 
possibility that local authorities can develop their own waste 
management plans.
EUROPEAN PARLIAMENT Council Directive 75/442/EEC of 
15 July 1975
Having regard to the Treaty establishing the European 
Economic Community Community, in particular Articles 100 
and 235, the Council of the European Communities, adopts 
measures concerning waste.
EUROPEAN PARLIAMENT Council Directive 2000/76/EC of 4 
December 2000.
Having Regard to The Treaty Establishing the European 
Community, and in particular Article 175 (1) thereof, and the 
Parlamient The European Council of the European Union, 
established on waste incineration.
1SNVS: National Sanitary Surveillance Department; 2CONAMA: National Environment Council; 3ANVISA: National Sanitary 
Surveillance Agency; 4ABNT: Brazilian Technical Norms Association; 5MMA: Ministry of the Environment; 6WHO: World Health 
Organization.
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(World Health Organization, 1999b). In the recommen-
dations on health waste management, medications are 
mentioned, but without much specificity.
The Guidelines for Safe Disposal of Unwanted 
Pharmaceutical in and after Emergencies published by 
WHO (World Health Organization, 1999a) is aimed at the 
officials of countries with the objective of implementing 
a policy for the management and final disposal of medi-
cations. The disposal methods covered are: return to the 
industry; disposal in landfills, whenever the residue is 
encapsulated or deactivated; in landfills with protection 
to the aquiferous and sewage systems; incineration in 
closed containers; incineration at medium temperatures; 
and chemical decomposition. However, according to 
Daughton (2003), the guide is better indicated for large 
volumes and emergency situations (Eickhoff et al., 
2009).
The WHO clarifies; through the national policy for 
the safe destination of health service’s waste and that the 
government is responsible for creating the regulations for 
this waste and ensures that the administrators of health as-
sistance centers assume the responsibility for guaranteeing 
the correct disposal. And this requires coordination that 
involves the Health Ministry as well as other ministries.
The Brazilian national environment system
The National Brazilian System – SISNAMA, is 
formed by the agencies and entities of the Union, the 
states, the Federal District, Municipalities and foundations 
of the various levels of the public authority responsible for 
the protection and quality of the environment, creating an 
environmental system management (Milaré, 2005).
SISNAMA has the following structure:
The Brazilian national sanitary surveillance 
system
The National Sanitary Surveillance Department 
(SNVS) was created in 1976; and in 1978, the Medication 
Division (Dimed) was created as the agency that controls 
and inspects the pharmaceutical industry in Brazil.
Still in 1976, the Sanitation Surveillance Law (Law 
No. 6360/1976) was approved, which restructured the 
norms for the registration and inspection of medications 
that required the prescription to be presented for the sale 
of medications, with the objective of controlling the con-
sumption of pharmaceuticals; and afterwards, with decree 
No. 79.094/77, which regulates Law No. 6360/76.
Another important fact was the creation of the Inte-
grated Health System (SUS), created by the Federal Con-
stitution of 1988 and defined through Law No. 8.080/90, 
to organize public health actions and services in Brazil. 
Law No. 9.782/99 was later approved, which created the 
National Sanitary Surveillance Agency (ANVISA), a 
regulatory milestone of the sector. ANVISA is an institu-
tion that belongs to the sanitary law, which composes the 
Integrated Health System, and it is responsible for the 
coordination of the National Sanitary Surveillance System, 
besides assuming the responsibility for other important 
programs and a large variety of products and services in 
order to reduce sanitary risks and make the promotion of 
the public’s health feasible.
Current Brazilian regulations
In August of 2010, Law No. 12.305 was published, 
which instituted the National Solid Waste Policy, and 
regulated in December of the same year by Decree No. 
7.404, and creates the National Solid Waste Policy’s 
Inter-ministerial Committee, for the implementation of 
the Reverse Logistics Systems (Brasil, 2010).
We emphasize that this law does not clarify the issue 
of medications and/or waste originated from medications. 
Therefore, there is still no specific legislation in effect in 
Brazil regarding the final disposal of medications. The 
issue is approached indirectly by the Ministry of Health 
and the Ministry of the Environment with technical regu-
lations for the management, treatment and final disposal 
of health service waste. Within this scope, we currently 
have the RDC Resolution No. 306, of December 7, 2004 
(National Sanitary Surveillance, 2008) and Conama 
Resolution No. 358, of April 29, 2005 (Ministry of the 
Environment, 2005).
Within the scope of RDC Resolution No. 17 of 2010 
regarding the Good Manufacturing Practices; section I, 
ORGANOGRAM 1 - Graphical representation of the structure 
of National Brazilian System.
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item XVIII states that there must be waste management 
in the self-inspection reports. 
The industrial waste control issue is already dealt 
with in CONAMA Resolution No. 006 of 1988. Article 1 
of the norm requires that industrial waste be the object of 
specific control, among the examples of types of industries 
subjected to this control, there is the inclusion of chemical 
industries with more than fifty employees.
The Pharmaceutical Industry is a considerable gen-
erator of solid waste due to the return and collection of 
medications from the market (distributors, pharmacies, 
drugstores and hospitals), discarding by quality control 
and losses inherent to the process (Falqueto et al., 2010).
For the companies that operate in the different stages 
of medication distribution (manufacturers, distributors, 
pharmacies, drugstores and hospitals), they must adapt to 
the sanitary legislation throughout the entire process, in 
which good transportation and storage practices must be 
included, as well as legislation referring to the environ-
ment, as for example, the National Environment Council 
(CONAMA) (Falqueto et al., 2010).
The pharmaceutical industries must observe the 
aforementioned legislation and specific considerations 
for their environmental licensing, which is a require-
ment proposed by the National Environment Policy for 
environmental control. The activity of manufacturing 
pharmaceutical products is inserted in the chemical in-
dustry topic of the list included in Conama Resolution 
No. 237, of 1997. It is necessary to pay attention to the 
requirements, because the pharmaceutical industries 
are also included in Law No. 9.605, de 1998 (“Environ-
mental Crimes Law”) through article 56 of the referred 
law (Pinto et al., 2009; Milaré et al., 2005; Junior et al., 
2005).
Current solid waste classification methods
The normative instructions for the current waste 
has adopted its classification criterion based on envi-
ronmental legislation and technical norm documents, 
especially in CONAMA Resolution No. 358/05, of the 
National Environment Council, in ABNT NBR 10.004 
Norm, of the Brazilian Technical Norms Association, and 
ANVISA RDC Resolution No. 306/04, of the National 
Sanitary Surveillance Agency (Falqueto et al., 2010; 
Pinto et al., 2009).
These norms use the term solid waste, in which 
waste in solid or semi-solid state are defined that result 
in activities from the community of origin: industrial, 
domestic, hospital, commercial, agricultural, services and 
sweepings (Pinto et al., 2009).
Solid waste classification according to ABNT NBR 
10.004
This norm classifies solid waste as to its potential 
risks to the environment and public health. The responsi-
bility for radioactive waste belongs to the National Nuclear 
Energy Committee (CNEN), and therefore, is not included 
in this norm (Pinto et al., 2009).
The process of waste classification, firstly involves 
the identification of the process or activity that originated 
them, their composition and characteristics, as well as the 
comparison of their composition with the lists of waste 
and substances whose impact to health and the environ-
ment is known. The classification reports can be based on 
the productive process itself, whenever the classification 
is included in the ABNT NBR 10.004 list. For this norm, 
waste is classified as shown in Table II.
Classification of solid waste according to ANVISA 
RDC No. 306/04 and CONAMA No. 358/05 
resolutions
These resolutions legislate especially in relation to 
the management, treatment and final disposal of health 
service waste.
For hazardous medication waste (HMW), according 
to the technical norm are classified as a subgroup of Group 
B (chemicals).
The HMWs can present the possibility of simultane-
ous classification, for example, a radioactive biological 
material.
Waste treatment and destination
Waste must be segregated, and each type of waste 
must be given a different treatment. Thus, before seg-
regating it, its final destination must be known. “Waste 
treatment is the application of a method, technique or 
process that changes the waste’s characteristics, reducing 
or eliminating the risk of contamination, work-related 
accidents or damage to the environment” (Brasil, 2004).
The final disposal of waste must meet construction 
and operation technical criteria that require environmental 
licensing according to CONAMA Resolution No. 237/97 
(Brasil, 1997b). Currently, the most common forms of final 
disposal of waste being used are:
Sanitary landfill: Technique for the final disposal of 
urban solid waste in the soil, by means of confinement in 
layers covered with inert material, according to specific 
norms, so as to avoid damage or risk to public health and 
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TABLE II - Classification of waste
Class Classification Description
Class I Hazardous Waste, which because of their physical, chemical or infecto-contagious properties, may 
present risks to public health. For example: products with flammable, corrosive, reactivity, 
toxicity and pathogenicity characteristics.
Class II Non-hazardous The non-hazardous waste was listed in the ABNT NBR 10.004.
Class II A Non-inert Those who do not fit the classifications of Class I waste - Hazardous waste or class II 
B - inert. The residue class II - not inert may have properties such as biodegradability, 
combustibility or water solubility.
Class II B Inert Any residues that, when sampled in a representative and subjected to a dynamic and 
static contact with distilled or deionized water at room temperature, do not have any of 
its constituents dissolved concentrations exceed the standards of potable water, except 
for appearance, color, haze, hardness and flavor.
TABLE IV - Classification of the types hazardous medication waste
Type 1 Hazardous medication that wasn’t used, was partially used, is expired or cannot be used
Hazardous medication originating from spills, as well as containment, absorption, removal and cleaning 
material contaminated by them
HEPA filters from safety cabins where hazardous medication is handled
Infusion pockets and equipment, filled or partially used, and other non-empty containers containing solutions 
of hazardous medications over the established limits
Type 2 Empty containers, including primary packages, when they are completely empty (for example: bottles, vials, 
pill blisters) and equipment, utensils or disposable devices
Personal Protective Equipment originating from the handling and preparation of hazardous medications and 
routine activities
Surface, workbench and safety cabin liners that had no direct contact with hazardous medications
TABLE II - Classification of waste.
Class Classification Description
Class I Hazardous Waste, which because of their physical, chemical or infecto-contagious properties, may present 
risks to public health. For example: products with flammable, corrosive, reactivity, toxicity 
and pathogenicity characteristics.
Class II Non-hazardous The non-hazardous waste was listed in the ABNT NBR 10.004.
Class II A Non-inert Those who do not fit the classifications of Class I waste - Hazardous waste or class II B - inert. 
The residue class II - not inert may have properties such as biodegradability, combustibility 
or water solubility.
Class II B Inert Any residues that, when sampled in a representative and subjected to a dynamic and 
static contact with distilled or deionized water at room temperature, do not have any of 
its constituents dissolved concentrations exceed the standards of potable water, except for 
appearance, color, haze, hardness and flavor.
guarantee safety, minimizing environmental impacts 
(Pinto et al., 2009).
Class I Hazardous Waste Landfill: Technique for 
the disposal of chemical waste in the soil, using specific 
engineering procedures for its confinement, without caus-
ing damage or risk to public health and reducing environ-
mental impact (Pinto et al., 2009).
The sanitary landfill norms are dealt with especially 
by ABNT NBR norm No. 13.896, of July 30 of 1997, 
which deals with Non-hazardous waste landfills – Criteria 
for the project, implementation and operation; CONAMA 
RESOLUTION No. 313, of October 29, 2002 / ANNEX 
III, which Regulates the national industrial solid waste 
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inventory; ABNT NBR 8418 and NBR 842 Abridgement 
on the Presentation of hazardous industrial waste landfill 
projects and ABNT NBR 1057 and NBR 1025 Abridge-
ment on the Hazardous waste landfills – Criteria for the 
project, construction and operation.
Co-processing: is the thermal destruction of waste 
in cement kilns. Its difference in relation to other burning 
techniques lies in the use of the waste as alternative fuel 
(for its energy potential), and as a raw material replace-
ment in the cement industry. In order to obtain a uniform 
feed in the cement kilns, the waste must be blended.
Co-processing is dealt with in Conama Resolution 
No. 264, of August 26 of 1999, which defines specific 
environmental licensing procedures, criteria and technical 
aspects for the co-processing of waste in revolving clinker 
kilns for the manufacturing of cement.
• Incineration: Is the destruction process via thermal 
oxidation performed in high temperatures, widely used for 
the treatment of hazardous waste (as for example: persis-
tent, toxic and flammable organic products). This process 
generates scoria and ash, which require final destination 
later (Pinto et al., 2009).
Regarding incineration, we have CONAMA RESO-
LUTION No. 6, of September 19 of 1991, which Regulates 
the incineration of solid waste originating from health 
establishments, ports and airports; CONAMA RESOLU-
TION No. 316, of October 29 of 2002, which Regulates 
procedures and criteria for the operation of waste thermal 
treatment systems; and ABNT NBR 11175, of August 30 
of 1990, which deals with Incineration of hazardous solid 
waste – Performance standards – Procedure
Pharmaceuticals in water treatment stations
“Residual pharmaceuticals present in domestic sew-
age and natural water is an issue that is being discussed 
internationally. Studies demonstrate that these pharmaceu-
ticals and their metabolites are present worldwide, such as 
Germany, Brazil, Canada, Holland, England, Italy, Sweden, 
the United States and the United Kingdom” (Bila et al., 
2003).
Pharmaceuticals are normally absorbed by the 
body and are subject to metabolic reactions. However, a 
significant quantity of these substances and their possible 
metabolites are eliminated through urine, feces or manure, 
being frequently found in domestic sewage. Studies report 
that in general, 40 to 90% of the administered dose is ex-
creted in its original form (Bila et al., 2003).
Once it is in the environment, the destination of 
pharmaceuticals depends on their structural characteristics 
and physical-chemical properties, such as photosensitiv-
ity, biodegradability and lipophilicity. Certain pharma-
ceuticals, such as acetylsalicylic acid and caffeine, are 
biodegradable and therefore, are efficiently removed at 
Sewage Treatment Stations (STS), reaching removal rates 
of 99.99%. Penicillin is also hardly found in the environ-
ment, due to the chemical imbalance of its β-lactamase 
ring (Bila et al., 2003).
Synthetic estrogens and tetracycline antibiotics tend 
to be absorbed by STS Iodine and /or sediments, due to their 
high lipophilicity and the precipitated forming of calcium 
and ions respectively similar (Castiglioni et al., 2006).
It is important to emphasize that in Brazil there is a 
greater incidence of pharmaceuticals in residual water due 
to the lack of sewage treatment in the country.
Conventional effluent treatment methods
There are currently several treatment methods that 
are being used, such as: coagulation, flocculation, sedi-
mentation, filtration, ionic exchange processes, adsorption 
with activated carbon, membrane separation, biodegrada-
tion, electro-chemical processes and photo-degradation 
(Melo et al., 2009; Bila et al., 2003).
Biological processes are more frequently used be-
cause they allow the treatment of large volumes and can 
reach a higher rate of organic matter removal at relatively 
low cost (Bila et al.,2003; Castiglioni et al., 2006; Bila et 
al., 2003).
In pharmaceutical biodegradation studies, the re-
moval rates were of 50% for conventional activated iodine 
systems (Melo et al., 2009; Bila et al., 2003).
Decantation, flotation, filtration and adsorption are 
processes characterized by the transfer of the contami-
nant phase and degradation does not necessarily occur. 
However, they are efficient and can be useful as pre or 
post-treatment of the final process. In Sewage Treatment 
Stations (STS), which operate with active iodine systems, 
the adsorption is the main mechanism for the removal of 
lipophilic pharmaceuticals, such as estrogens (Melo et al., 
2009; Bila et al., 2003).
The efficiency of pharmaceutical removal in STSs 
depends on the physical-chemical properties of each com-
pound. For example, for carbamazepine, an anticonvul-
sant, a removal of 7% was observed, while acetylsalicylic 
acid had a removal rate of 99% in a STS in Germany. This 
oscillation in the rate of removal was also observed in a 
STS in Finland, where 26% of removal was obtained for 
Diclofenac and 92% for Ibuprofen. Polar compounds tend 
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to remain in their aqueous phase, which favors their infil-
tration into the aquatic environment. On the other hand, 
non-polar compounds are removed by adsorption in iodine 
(Melo et al., 2009; Bila et al., 2003).
Advanced oxidative processes for the degradation 
of residual pharmaceuticals
The advanced oxidative processes (AOP) are pre-
sented as alternatives or supplements to the traditional 
treatment processes of effluents, because the hydroxyl 
radicals that are generated are very reactive and not se-
lective, and act in an interesting manner in the chemical 
oxidation of several substances (Huber et al., 2003).
These radicals may react with organic contaminants 
through distinct mechanisms, depending on the molecular 
structure. Examples of oxidative processes: hydrogen 
peroxide photolysis, ozonation, heterogeneous photoca-
talysis, Fenton and photo-Fenton (Klavarioti et al., 2009).
“AOP degradation of pharmaceuticals, as well as 
direct photolysis (which depends on each compound’s 
absorbance), involves different stages and various reac-
tions that result in different sub-products, which may pres-
ent greater or less toxicity in comparison to the original 
pharmaceutical.” (Melo et al., 2009).
These intermediaries may maintain, or not, the 
functional activity of the original compound. In studies, 
the toxicity and biodegradability of the intermediaries of 
a sulfamethoxazole antibiotic solution (200 mg/L) were 
evaluated after the application of the photo-Fenton pro-
cess. Through the results of the DBO/DQO ratio, it was 
observed that by increasing the dose of H2O2 from 50 to 
550 mg/L during the treatment, there was an increase in 
biodegradability. Other reported relevant information was 
that for a lower dose of H2O2 (50 mg/L) being used, there 
was an increase in the solution’s toxicity, which indicates 
that in this condition, intermediaries that were more toxic 
than the original pharmaceutical. However, this was not 
observed when using greater concentrations of H2O2, 
which suggested that the intermediaries being formed may 
be different depending on the experimental conditions, or 
that these compounds are quickly degraded (Balcioglu et 
al., 2003; Melo et al., 2009).
The degradation of sulfamethoxazole was also eval-
uated by heterogeneous photo-catalysis. It was observed 
that the COT removal efficiency varied due to the pH. The 
factor indicated as being responsible for this variation was 
the difference in degradation routes, which lead to the for-
mation of compounds that do not contain the benzene ring 
or the isoxazole ring. The DBO/DQO ratio demonstrated 
the increase in biodegradability of the sulfamethoxazole 
solution after the application of the heterogeneous photo-
catalysis, thus emphasizing the applicability of this treat-
ment (Balcioglu et al., 2003; Andreozzi et al., 2004).
Studies have demonstrated that the DBO/DQO 
ratio demonstrated the increase in biodegradability of 
the sulfometoxazol solution after the application of the 
heterogeneous photo-catalysis, thus emphasizing the ap-
plicability of this treatment (Andreozzi et al., 2004; Melo 
et al., 2009).
The optimization of the treatment processes is es-
sential in order to guarantee the complete mineralization 
of the target-compounds, reducing the formation of toxic 
intermediaries. Thus, the development of sensitive ana-
lytical methods is necessary in order to identify possible 
intermediaries and reliable toxicity tests to prevent the 
impact of these substances to the environment (Castiglioni 
et al., 2006; Melo et al., 2009).
There is still little information regarding the char-
acteristics of degradation products formed from pharma-
ceuticals excreted after being treated, this information is 
fundamental to ensure the effectiveness and safety of the 
application of such effluent treatment processes containing 
pharmaceutical waste (Melo et al., 2009).
Analytical methods used in the identification of 
pharmaceuticals
For STS effluents, the analysis of residual pharma-
ceuticals in rivers, subsoil and potable water, requires the 
development of more sensitive analytical methods for the 
detection of concentrations with the µg/L and ng/L range, 
than those performed in biological samples such as blood, 
urine and others (Bila et al., 2003).
There is a growing concern with the presence of 
pharmaceuticals in aquatic environments, the monitoring 
of the removal efficiency of these pharmaceuticals through 
conventional domestic effluent treatment by the STSs 
is of great importance, because in the future, there will 
be the need to adapt, or even implement supplementary 
processes for the proper removal of such pharmaceuticals 
(Bila et al., 2003).
The public’s awareness of the problem 
A study conducted at the Campinas State University 
-UNICAMP approached the public’s knowledge regarding 
the problems caused by the domestic disposal of medica-
tions, by means of a questionnaire. The survey was based 
on the environment at the university’s campus at 4 collec-
tions points and presented a sample of 141 people (Ueda 
et al., 2009.)
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Through an analysis of the data presented, it was 
verified that it is not only important to promote the imple-
mentation of collection policies, because only a restricted 
part of the public is aware of the problem (Ueda et al., 2009.)
CONCLUSION
In general, Brazil already has regulations regarding 
waste management, it is necessary to supplement and 
update with the existing norms and legislation.
Health professionals who work directly in health-
care and pharmaceutical industries, practice and have the 
knowledge about the environmental management poli-
cies. The big discussion is how to enable a proper reverse 
logistics of medicines and which will be responsible on 
this direct operational management taking into consider-
ation socio-economic diversity and the large extension of 
Brazilian territory.
ANVISA has already initiated studies about the dis-
posal of medication waste, as well as the revision process 
of the current RDC No. 306/04 resolution. The state of São 
Paulo has a more current regulation, Administrative Rule 
CVS No. 21 of September 19 of 2008 (São Paulo, 2008), 
which deals, in a peculiar manner, with the classification 
of hazardous medication waste and takes international 
references about the issue into consideration. State and 
international experiences can help to supplement current 
federal legislation.
The guidance and monitoring of the habits of the 
population is part of the construction of an organized 
policy on the proper storage and disposal of residential 
medicines (Alvarenga et al., 2010)
Plans based on environmental education and in 
public policies, in the manufacturing process as well as in 
the amount of medication prescribed, must be discussed 
with the various sectors of society, in order to minimize the 
generation of waste. Additionally, there must be incentives 
for the development of technological research that make 
lower costs, environmental impact viable and that provide 
an improvement in the public’s quality of life.
The importance of the participation of society, 
governmental agencies and the entire productive chain is 
fundamental, because they participate directly as protago-
nists in this context. 
We can conclude that there is the need for a medica-
tion waste disposal management program aiming at correct 
handling procedures and the definition of the responsi-
bilities in the various actions, in order to reduce possible 
sanitary risks for public health. 
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